Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinoma
Ann Transl Med
.
2018 Dec;6(Suppl 2):S104.
doi: 10.21037/atm.2018.11.37.
Authors
Francesco A Mistretta
1
2
,
Elio Mazzone
1
3
4
,
Sophie Knipper
1
5
,
Pierre I Karakiewicz
1
6
Affiliations
1
Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Québec, Canada.
2
Department of Urology, European Institute of Oncology, Milan, Italy.
3
Division of Oncology, Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
4
Vita-Salute San Raffaele University, Milan, Italy.
5
Martini-Klinik, Prostate Cancer Centre, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
6
Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada.
PMID:
30740425
PMCID:
PMC6330610
DOI:
10.21037/atm.2018.11.37
No abstract available
Publication types
Editorial
Comment